trending Market Intelligence /marketintelligence/en/news-insights/trending/um2lCe-wmZdbKkKhg4FuAg2 content esgSubNav
In This List

Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Innovus Pharmaceuticals Inc. is implementing a 1-for-105 reverse split of its common stock.

The San Diego-based pharmaceutical company said its stock will begin trading on a split-adjusted basis on the OTCQB marketplace at the opening of trading March 18.

The reverse stock split was approved by a majority of Innovus' stockholders Feb. 22.